These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9256796)

  • 21. Are local recurrences after breast conserving therapy more frequent in patients with BRCA1/BRCA2 mutations?
    Kurtz JM
    Strahlenther Onkol; 2000 Sep; 176(9):433-4. PubMed ID: 11050918
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic susceptibility to breast and ovarian cancer.
    Skolnick MH; Frank T; Shattuck-Eidens D; Tavtigian S
    Pathol Biol (Paris); 1997 Mar; 45(3):245-9. PubMed ID: 9296070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons learned from BRCA1 and BRCA2.
    Zheng L; Li S; Boyer TG; Lee WH
    Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers.
    Shih HA; Nathanson KL; Seal S; Collins N; Stratton MR; Rebbeck TR; Weber BL
    Clin Cancer Res; 2000 Nov; 6(11):4259-64. PubMed ID: 11106241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women.
    Noguchi S; Kasugai T; Miki Y; Fukutomi T; Emi M; Nomizu T
    Cancer; 1999 May; 85(10):2200-5. PubMed ID: 10326698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic testings for cancer: the surgeon's critical role. Familial breast cancer.
    Weber BL
    J Am Coll Surg; 1999 Jan; 188(1):79-86. PubMed ID: 9915248
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
    Ost E; Illiger HJ
    Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
    [No Abstract]   [Full Text] [Related]  

  • 30. BRCA 1, BRCA 2 models.
    Engman ML; Pinkham CA
    J Insur Med; 1996; 28(2):119-20. PubMed ID: 10163945
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical and genetic characterisation shows that the BRCA1 IVS20 insertion is a polymorphism.
    Scholl T; Pyne MT; Ward B; Pruss D
    J Med Genet; 1999 Jul; 36(7):571-2. PubMed ID: 10424822
    [No Abstract]   [Full Text] [Related]  

  • 32. p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours.
    Crook T; Brooks LA; Crossland S; Osin P; Barker KT; Waller J; Philp E; Smith PD; Yulug I; Peto J; Parker G; Allday MJ; Crompton MR; Gusterson BA
    Oncogene; 1998 Oct; 17(13):1681-9. PubMed ID: 9796697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer screening for high-risk women: too little, too late?
    Armstrong K; Weber BL
    J Clin Oncol; 2001 Feb; 19(4):919-20. PubMed ID: 11181652
    [No Abstract]   [Full Text] [Related]  

  • 34. Location of BRCA1 in human breast and ovarian cancer cells.
    Scully R; Ganesan S; Brown M; De Caprio JA; Cannistra SA; Feunteun J; Schnitt S; Livingston DM
    Science; 1996 Apr; 272(5258):123-6. PubMed ID: 8600523
    [No Abstract]   [Full Text] [Related]  

  • 35. Tough decisions.
    Craft M
    Intercom (Des Moines); 1987; 87(4):5. PubMed ID: 3693991
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute care decisions--ethics in action.
    Haddad A
    RN; 1997 Jul; 60(7):17-20. PubMed ID: 9256796
    [No Abstract]   [Full Text] [Related]  

  • 37. [BRCA1 and BRCA2--breast cancer susceptibility genes].
    Dagan E; Gershoni-Baruch R
    Harefuah; 1997 Nov; 133(10):455-7. PubMed ID: 9418320
    [No Abstract]   [Full Text] [Related]  

  • 38. BRCA1. A new marker in the management of patients with breast cancer?
    Offit K
    Cancer; 1996 Feb; 77(4):599-601. PubMed ID: 8616748
    [No Abstract]   [Full Text] [Related]  

  • 39. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.